Health -
Highly Anticipated New Treatment Option Now Available for Canadians with Select Type of Thyroid Cancer
LENVIMA™ (lenvatinib) Demonstrated an Unprecedented Improvement in Progression-Free Survival (PFS) and a Statistically Significant Overall Response Rate in Patients with […]